Announcements Trials
Browse Landscape

Status

Withdrawn 1Terminated 1Completed 1

Sponsor Class

OTHER 3

Study Type

Observational 3

Sponsor

Cancer Type

Gastrointestinal 3Other 1Gynecologic 1Genitourinary 1Breast 1

Conditions

Neoplasms 47Breast Neoplasms 32Colorectal Neoplasms 28Prostatic Neoplasms 27Lung Neoplasms 16Hematopoietic and Lymphatic System Neoplasm 12Hematologic Neoplasms 12Ovarian Neoplasms 11Uterine Cervical Neoplasms 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Multiple Myeloma 7Lymphoma 7Leukemia 7Head and Neck Neoplasms 6Endometrial Neoplasms 6Depression 6Rectal Neoplasms 5Pancreatic Neoplasms 5Urinary Bladder Neoplasms 4Mouth Neoplasms 4Motor Activity 4Melanoma 4Malignant Solid Neoplasm 4Leukemia, Myeloid, Acute 4Hematopoietic and Lymphoid System Neoplasm 4Gastrointestinal Neoplasms 4Colonic Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Anxiety Disorders 4Advanced Cancer 4

Interventions

Oxaliplatin 295Capecitabine 209Fluorouracil 183Cisplatin 172Docetaxel 140S 1 (combination) 135Paclitaxel 128Leucovorin 117Irinotecan 110pembrolizumab 104Trastuzumab 75Nivolumab 59apatinib 57Drug Therapy 52sintilimab 46Surgical Procedures, Operative 45Ramucirumab 40Radiotherapy 40Bevacizumab 37Hyperthermic Intraperitoneal Chemotherapy 34Epirubicin 32titanium silicide 31tislelizumab 31Carboplatin 31Gastrectomy 28Cyclophosphamide 27XELOX 25Tegafur 24Folfox protocol 23Albumin-Bound Paclitaxel 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Stomach Neoplasms × Interviews as Topic × Clear all
NCT03563352 2020-12-14

Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements in Participants With Breast, Colorectal, Upper Gastrointestinal, or Prostate Cancer

University of Southern California

Withdrawn
BreastGastrointestinalGenitourinary

Breast Neoplasms, Gastrointestinal Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

NCT00394602 2020-01-02

Chemoradiation-Induced Nausea and Emesis: Quality of Life

M.D. Anderson Cancer Center

Terminated
207 enrolled
GastrointestinalGynecologic

Anus Neoplasms, Uterine Cervical Neoplasms, Nausea, Pancreatic Neoplasms, Stomach Neoplasms, Vomiting, Vulvar Neoplasms, Endometrial Neoplasms

NCT01518023 2012-01-25

Long Term Diabetes Improvement After Cancer Gastrectomy and Colectomy

University of Sao Paulo

Completed
240 enrolled
GastrointestinalOther

Diabetes Mellitus, Obesity, Morbid, Prediabetic State, Stomach Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡